Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. - Wikidata - wikimedia - TriplyDB

Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.

Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.

http://www.wikidata.org/entity/Q45149873

about

Natural regression of fibrosis in chronic hepatitis B Imaging Based Methods of Liver Fibrosis Assessment in Viral Hepatitis: A Practical Approach Current and future directions for treating hepatitis B virus infection Non-invasive assessment of liver fibrosis in chronic hepatitis B.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis.Non-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup.The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.SASLT practice guidelines for the management of hepatitis B virus.Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.Hepatitis B: are non-invasive markers of liver fibrosis reliable?FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis.Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.The prognosis and management of inactive HBV carriers.The use of transient elastography in the management of chronic hepatitis B.Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013.Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus.The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection.JSH Guidelines for the Management of Hepatitis B Virus Infection.A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.Quantitative elastography of renal transplants using supersonic shear imaging: a pilot study.Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B.Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis.

P2860

Q26746929-875194C9-161D-462B-A7E1-CE620AE13C35 Q26771433-816F3B69-695A-498F-B3F9-6B464EC75EA8 Q26851240-415BD46A-D11A-4188-8EC7-BC95C19C44FB Q30427489-D8F5998C-64A9-472D-AA2C-A7E4AA567A5B Q30430774-A9AD6A5F-1775-4BE7-8BFC-555FEC82D1B1 Q30472899-F8940D00-8F62-4499-B580-366A9054EB00 Q36546657-7C683A05-BD64-42F2-A36A-B18F9AFD3997 Q37156348-6A11FE0D-AB99-4DEF-8859-3EC0BB030028 Q37634822-92456BA4-B7EE-4F92-82D9-585018E628CD Q37706873-D1F1F871-8929-4DD2-B287-E6F9E996E46B Q38174256-3D88A04A-5266-43F8-8814-45D05EF02360 Q38188809-33D2E77B-85E8-4198-A4C8-E173C9B8D4AA Q38240784-D07F8DBF-4F2A-4719-8035-255D1D46B340 Q38297230-F14DA604-1FDD-4361-8D44-64B52A140AD1 Q38685595-A965B65F-298C-4431-8A02-AF652680B6FA Q39099395-8D38B6E2-98B9-491E-8FB9-B19A9334438C Q39377075-F6894A33-20B1-429C-AB33-1C0AA2E186E5 Q42208113-C00C66B4-AC15-4B14-9AE1-0710C9AAEC39 Q42223347-C7EF44DE-0F3C-448A-9DF0-7FD0B353A656 Q42244740-236A5F79-7C67-4D03-B85E-22D14C9BFF2A Q42263583-280194B6-C992-4753-BF3A-0C62FB0E2F0B Q44595693-8812A6F5-D6B0-464E-AA07-E2476E299B6A Q45760761-E8A18A1F-5A15-489E-BD54-76706AA2891B Q47101834-488CD849-1EED-4A80-86F0-0BC9AFAE313D Q50041595-ACEDF15F-741F-478E-B2DE-150E20ABF26B Q51562701-1520A0BE-2904-4393-BF7E-EA010BA92D1D Q52692830-AFBF8975-E5A3-47E5-A723-AA9B2F4C3589 Q55438231-3B3857E9-F6E6-494E-AED6-3793ED608EF6

P2860

Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.

http://www.wikidata.org/entity/Q45149873

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Transient elastography and bio ...... inactive hepatitis B carriers.

@en

Transient elastography and bio ...... inactive hepatitis B carriers.

@nl

type

label

Transient elastography and bio ...... inactive hepatitis B carriers.

@en

Transient elastography and bio ...... inactive hepatitis B carriers.

@nl

prefLabel

Transient elastography and bio ...... inactive hepatitis B carriers.

@en

Transient elastography and bio ...... inactive hepatitis B carriers.

@nl

P1433

Q45149873-50E6622B-5031-4B9E-A543-1EE5A3105D04

P1476

Q45149873-AB6912FC-69A4-41CD-BF57-A0FD2BBFF224

P2093

Q45149873-176EF624-1D11-4186-A5C0-6F62CA9FC941

Q45149873-32E76001-AE83-4D02-879B-ABA7C61E647D

Q45149873-421FD727-2F89-43DE-9231-72A77E27BF76

Q45149873-53FE0659-5C92-410A-916A-D3F9F0F83388

Q45149873-657E9396-2CA4-4E56-8937-945D321FD097

Q45149873-A7FA5D06-8567-4401-8E02-ABB040BC05A5

Q45149873-BA21E602-6F67-4BE1-8233-B2DE6C058D0D

Q45149873-D45F1871-9D1E-4883-9B62-970476D083DF

P2860

Q45149873-14C61BDB-499E-4930-A41F-0E9EACB52CF4

Q45149873-17034B2E-0311-4E44-8F88-6873B179DA91

Q45149873-1F4B8573-46C2-41E1-B6DB-48027D28C68F

Q45149873-257BF108-DF93-40D2-823B-EF3FF79DA159

Q45149873-32A74540-09D5-474A-8B48-24F29077CA17

Q45149873-37CA48F8-25DF-41FD-9B6F-3AA1CB96014D

Q45149873-466C33B8-F92E-4AFB-AB16-1C3F7CE78FA5

Q45149873-4F2D8FCB-1572-4ACC-B530-23134B20F0E5

Q45149873-50062E79-011E-4508-8E7E-D22130C273F9

Q45149873-562D0E91-84D2-4EB8-BAF5-A733DAACBE79

P304

Q45149873-17BA63C5-8AF0-4262-AEE4-9F35B59ABF16

P31

Q45149873-0C9C89B1-4E2B-4E6E-8B67-D0E3F078B0FB

P356

Q45149873-A943BAEE-13C8-448A-BE4F-7B1755BD4EB9

P407

Q45149873-14E24D84-C9A1-4D4D-A7F9-A84224B9FC54

P433

Q45149873-CB7A37DB-E991-4964-B10F-83DC51F33303

P478

Q45149873-CC6A34EF-D424-47B6-A489-D517C2FF7F0A

P577

Q45149873-D066558C-FA36-4560-800A-67818D552A7B

P5875

Q45149873-F5E156CE-128C-4B7D-A11B-0CF4D384F205

P698

Q45149873-8477D2F4-601B-4733-A69D-287B935B1F3D

P921

Q45149873-3FCE9680-9BBC-4822-8A2F-4C717654F4D6

P356

J.1365-2036.2010.04547.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Transient elastography and bio ...... inactive hepatitis B carriers.

@en

P2093

B Le Bail

http://www.w3.org/2001/XMLSchema#string

J Foucher

http://www.w3.org/2001/XMLSchema#string

L Castéra

http://www.w3.org/2001/XMLSchema#string

P Couzigou

http://www.w3.org/2001/XMLSchema#string

P Trimoulet

http://www.w3.org/2001/XMLSchema#string

P-H Bernard

http://www.w3.org/2001/XMLSchema#string

V de Lédinghen

http://www.w3.org/2001/XMLSchema#string

W Merrouche

http://www.w3.org/2001/XMLSchema#string

P2860

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Chronic hepatitis B: update 2009

Meta-analyses of FibroTest diagnostic value in chronic liver disease.

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

Management of hepatitis B: 2000--summary of a workshop.

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.

P304

455-465

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2036.2010.04547.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49756017

http://www.w3.org/2001/XMLSchema#string

P698

21235598

http://www.w3.org/2001/XMLSchema#string

P921